Dario Eklund
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Dario Eklund is currently the Chief Executive Officer at Santhera Pharmaceuticals Holding AG since 2019.
Formerly, the roles included Commercial Director at Novartis AG from 1994 to 2002, General Manager-Switzerland at Sanofi from 2002 to 2004, VP-Business Development & Gintuit Business Unit at Organogenesis, Inc. from 2004 to 2014, Head-Global Business Operations at Vifor Pharma Management AG from 2014 to 2019, Chief Commercial Officer at Corden Pharma Fribourg SA from 2017 to 2019, Member-Supervisory Board at Vifor Fresenius Medical Care Renal Pharma Ltd. from 2017 to 2019, and General Manager-Switzerland Region at Aventis Pharma AG.
Education includes graduate studies at Hanken Svenska Handelshögskolan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2024 | 110.526 ( 0,74 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Director Ejecutivo | 01/12/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Corporate Officer/Principal | 30/09/2019 |
| VIFOR PHARMA | Corporate Officer/Principal | 30/09/2019 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Director/Miembro de la Junta | 01/01/2019 |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Corporate Officer/Principal | 01/01/2014 |
| SANOFI | Corporate Officer/Principal | 01/01/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Aventis Pharma AG | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Hanken Svenska Handelshögskolan
Hanken Svenska Handelshögskolan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.